Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt. / Rohde, Ulrich; Gylvin, Silas; Vilmann, Peter; Friis, Steffen Ulrik; Langholz, Ebbe; Vilsbøll, Tina; Knop, Filip Krag.

I: Ugeskrift for Laeger, Bind 176, Nr. 37, 29.09.2014, s. 1874-1877.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Rohde, U, Gylvin, S, Vilmann, P, Friis, SU, Langholz, E, Vilsbøll, T & Knop, FK 2014, 'Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt', Ugeskrift for Laeger, bind 176, nr. 37, s. 1874-1877.

APA

Rohde, U., Gylvin, S., Vilmann, P., Friis, S. U., Langholz, E., Vilsbøll, T., & Knop, F. K. (2014). Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt. Ugeskrift for Laeger, 176(37), 1874-1877.

Vancouver

Rohde U, Gylvin S, Vilmann P, Friis SU, Langholz E, Vilsbøll T o.a. Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt. Ugeskrift for Laeger. 2014 sep. 29;176(37):1874-1877.

Author

Rohde, Ulrich ; Gylvin, Silas ; Vilmann, Peter ; Friis, Steffen Ulrik ; Langholz, Ebbe ; Vilsbøll, Tina ; Knop, Filip Krag. / Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt. I: Ugeskrift for Laeger. 2014 ; Bind 176, Nr. 37. s. 1874-1877.

Bibtex

@article{049cd24c4bc946ca8d76d738ac7701b9,
title = "Behandling med duodenal-jejunal bypass-sleeve ved sv{\ae}r overv{\ae}gt",
abstract = "Overweight and obesity are risk factors for several co-morbidities reducing life expectancy. Conservative treatment of obesity is generally ineffective in the long-term. Bariatric surgery has proven effective, but is associated with potential complications. Duodenal-jejunal bypass sleeve is a novel minimal invasive and fully reversible endoscopic treatment modality approved for treatment of obesity with or without concomitant type 2 diabetes. Here we review present data for the efficacy and safety of this treatment modality.",
author = "Ulrich Rohde and Silas Gylvin and Peter Vilmann and Friis, {Steffen Ulrik} and Ebbe Langholz and Tina Vilsb{\o}ll and Knop, {Filip Krag}",
year = "2014",
month = sep,
day = "29",
language = "Dansk",
volume = "176",
pages = "1874--1877",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "37",

}

RIS

TY - JOUR

T1 - Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt

AU - Rohde, Ulrich

AU - Gylvin, Silas

AU - Vilmann, Peter

AU - Friis, Steffen Ulrik

AU - Langholz, Ebbe

AU - Vilsbøll, Tina

AU - Knop, Filip Krag

PY - 2014/9/29

Y1 - 2014/9/29

N2 - Overweight and obesity are risk factors for several co-morbidities reducing life expectancy. Conservative treatment of obesity is generally ineffective in the long-term. Bariatric surgery has proven effective, but is associated with potential complications. Duodenal-jejunal bypass sleeve is a novel minimal invasive and fully reversible endoscopic treatment modality approved for treatment of obesity with or without concomitant type 2 diabetes. Here we review present data for the efficacy and safety of this treatment modality.

AB - Overweight and obesity are risk factors for several co-morbidities reducing life expectancy. Conservative treatment of obesity is generally ineffective in the long-term. Bariatric surgery has proven effective, but is associated with potential complications. Duodenal-jejunal bypass sleeve is a novel minimal invasive and fully reversible endoscopic treatment modality approved for treatment of obesity with or without concomitant type 2 diabetes. Here we review present data for the efficacy and safety of this treatment modality.

M3 - Tidsskriftartikel

C2 - 25294038

VL - 176

SP - 1874

EP - 1877

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 37

ER -

ID: 137372404